Published 14 hours ago • loading... • Updated 4 hours ago
Australia’s National Medical Research Body Advises Conditional Use of Puberty Blockers for Transgender Children
The council said the drugs may remain an option for some children, but evidence is low-certainty and states can still set access rules.
On Monday, the National Health and Medical Research Council released interim advice stating that puberty suppressants can be a treatment option for trans and gender-diverse youth under 18.
Health Minister Mark Butler commissioned the review last year to guide clinical practice in this contested, evolving area and ensure vulnerable youth receive care grounded in evidence.
Using the GRADE approach, the council evaluated 15 studies involving 12,756 people and found the medication may improve psychosocial functioning and reduce suicidality, though evidence certainty remains low.
Queensland and the Northern Territory face a policy test, as both governments have banned or restricted the treatment in public systems while Butler urges states to align services with the advice.
Public consultation remains open until January, and the council will release comprehensive national guidelines for gender-affirming care in 2028, broadening beyond puberty suppressants.